Comment on Catanzaro et al. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data. J. Pers. Med. 2024, 14, 222
Open Access
- 21 January 2026
- journal article
- editorial
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (1) , 54
Abstract
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by progressive inflammation and fibrosis of the intra- and extrahepatic bile ducts, and is often associated with inflammatory bowel disease (IBD)Keywords
This publication has 8 references indexed in Scilit:
- Elucidating the Role of Galectin-3 in the Recurrence of Primary Sclerosing Cholangitis Post-Liver Transplantation as a Potential Therapeutic TargetCurrent Topics in Medicinal Chemistry, 2025
- Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center DataJournal of Personalized Medicine, 2024
- Intestinal Bacteremia After Liver Transplantation Is a Risk Factor for Recurrence of Primary Sclerosing CholangitisTransplantation, 2023
- Letter to the Editor: The mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. Is the dysbiosis index really predictive for the recurrence of PSC?Hepatology, 2023
- Recurrence of primary sclerosing cholangitis after liver transplantation – analysing the European Liver Transplant Registry and beyondTransplant International, 2021
- Hypothermic Machine Perfusion in Liver Transplantation — A Randomized TrialNew England Journal of Medicine, 2021
- Outcomes and risk factors for recurrence of disease in adult liver transplantation due to Primary Sclerosing Cholangitis: a single-centre experienceDigestive and Liver Disease, 2021
- Roux-en-Y Choledochojejunostomy Versus Duct-to-Duct Biliary Anastomosis in Liver Transplantation for Primary Sclerosing Cholangitis: A Meta-AnalysisTransplantation Proceedings, 2013